Daré Bioscience (DARE) Short Interest Ratio & Short Volume

Short interest is the volume of Daré Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 290,300 shares of DARE short. Learn More on Daré Bioscience's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Daré Bioscience: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Daré Bioscience saw a increase in short interest in April. As of April 30th, there was short interest totaling 290,300 shares, an increase of 17.6% from the previous total of 246,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Daré Bioscience: Acurx Pharmaceuticals, Inc. (4.67%), Viracta Therapeutics, Inc. (2.54%), Theratechnologies Inc. (0.10%), NRx Pharmaceuticals, Inc. (6.36%), Spruce Biosciences, Inc. (0.97%), Enlivex Therapeutics Ltd. (1.42%), ImmunoPrecise Antibodies Ltd. (1.45%), Fortress Biotech, Inc. (12.69%), Aprea Therapeutics, Inc. (1.90%), Acasti Pharma Inc. (0.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling DARE is an investing strategy that aims to generate trading profit from Daré Bioscience as its price is falling. DARE shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Daré Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DARE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DARE, twice per month. The most recent reporting period available is April, 30 2024.